Peter Kolchinsky founded RA Capital Management in 2001 and focuses mainly on healthcare stocks. One of the few hedge fund managers who actually holds...
Keep Reading →
February 25 - Hedge Funds, News - Comments
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in the third quarter, blaming macroeconomic conditions...
Keep Reading →
December 1 - Hedge Funds, News - Comments
With the Fed having postponed the rate hike again, companies are taking full advantage of the low interest rates to finance their diversification and...
Keep Reading →
November 2 - Market Movers, News - Comments
Shares of Dyax Corp. (NASDAQ:DYAX), Bill Barrett Corporation (NYSE:BBG), and MeetMe Inc (NASDAQ:MEET) are up by 12.5%, 11.1%, and 15% respectively in...
Keep Reading →
October 15 - Market Movers, News - Comments
Peter Kolchinsky‘s RA Capital Management recently filed its 13F with the SEC for the reporting period of June 30. Peter Kolchinsky started RA Capital...
Keep Reading →
August 15 - Hedge Fund Analysis, Hedge Funds, News - Comments
According to a recent filing with the Securities and Exchange Commission, Peter Kolchinsky‘s RA Capital has initiated a position in Alcobra Ltd (...
Keep Reading →
July 8 - Hedge Funds, News - Comments
Is it smart to be bullish on Dyax Corp. (NASDAQ:DYAX)? Now, according to many of your fellow readers, hedge funds are viewed as delayed, old investment...
Keep Reading →
September 6 - News - Comments
Now, according to many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age. Although there are over 8,000...
Keep Reading →
September 3 - News - Comments
Should investors bullish on QLT Inc. (USA) (NASDAQ:QLTI) consider the following data? In the financial world, there are many indicators shareholders...
Keep Reading →
August 30 - News - Comments
Thousands of Americans suffer from a rare and painful disease every year. This inherited disease is called Hereditary Angioedema, or HAE for short. Its...
Keep Reading →
July 2 - News - Comments
Amgen, Inc. (NASDAQ:AMGN) is half way there. The biotech giant announced today that its cancer drug trebananib combined with chemotherapy paclitaxel extended...
Keep Reading →
June 13 - News - Comments
Dyax Corp. (NASDAQ:DYAX) has seen an increase in support from the world’s most elite money managers in recent months. In the eyes of most traders...
Keep Reading →
June 10 - News - Comments
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) was in 12 hedge funds’ portfolio at the end of the first quarter of 2013. SPPI has experienced a decrease...
Keep Reading →
June 6 - News - Comments
QLT Inc. (USA) (NASDAQ:QLTI) has seen a decrease in enthusiasm from smart money recently. In today’s marketplace, there are tons of metrics shareholders...
Keep Reading →
June 3 - News - Comments
There’s never a shortage of losers in the stock market. Let’s take a closer look at five of this past week’s biggest sinkers. Company...
Keep Reading →
April 28 - News - Comments
Is Dyax Corp. (NASDAQ:DYAX) the right investment to pursue these days? The best stock pickers are taking a bullish view. The number of long hedge fund...
Keep Reading →
April 1 - News - Comments
Since sequestration kicked in on Saturday and The End of The World As We Know It was supposed to materialize, the Dow Jones Industrial Average has packed...
Keep Reading →
March 6 - News - Comments
